Study guide

8.4 Social Determinants of Health in Treatment Planning

Board Certified Pharmacotherapy Specialist BCPS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction and Exam Logistics

1.1 About the BCPS Exam & BPS Specialty Board 1.2 Eligibility, Registration, and Pearson VUE Logistics 1.3 Study Strategies & Exam-Taking Skills for BCPS

2 Chapter 2: Therapeutics: Cardiovascular & Pulmonary

2.1 Cardiovascular Pharmacotherapy 2.2 Pulmonology & Respiratory Care 2.3 Critical Care & Emergency Medicine

3 Chapter 3: Therapeutics: Infectious Diseases

3.1 Infectious Diseases: Antimicrobial Stewardship & Pharmacokinetics 3.2 Infectious Diseases: Common & Severe Infections 3.3 Infectious Diseases: Specialty Infections

4 Chapter 4: Therapeutics: Renal, Endocrine & Gastrointestinal

4.1 Nephrology & Renal Pharmacotherapy 4.2 Endocrinology & Diabetes Mellitus 4.3 Gastroenterology & Hepatic Disorders

5 Chapter 5: Therapeutics: Neurology, Psychiatry & Pain Management

5.1 Pain Management & Palliative Care 5.2 Neurologic Pharmacotherapy 5.3 Psychiatric Pharmacotherapy

6 Chapter 6: Therapeutics: Special Populations

6.1 Geriatric Pharmacotherapy & Beers Criteria 6.2 Pediatric & Neonatal Pharmacotherapy 6.3 Women's Health

7 Chapter 7: Therapeutics: Oncology, Nutrition & Immunology

7.1 Oncology & Support Care 7.2 Nutrition Support 7.3 Immunology, Allergy, & Vaccine-Preventable Diseases 7.4 Urologic Disorders: BPH, Overactive Bladder, and Erectile Dysfunction

8 Chapter 8: Patient Care: Therapeutics & Patient Management

8.1 Clinical Assessment & Patient History 8.2 Clinical Pharmacokinetics: Dosing, Clearance, Vd, and TDM 8.3 Therapeutic Implementation & Medication Reconciliation 8.4 Social Determinants of Health in Treatment Planning

9 Chapter 9: Patient Care: Treatment Monitoring & Outcomes

9.1 Patient Counseling, Education, & Adherence 9.2 Treatment Monitoring: Efficacy, Targets, & Lab Interpretation 9.3 Adverse Drug Event (ADE) Detection & Management

10 Chapter 10: Professional Practice & Evidence-Based Medicine

10.1 Research Methodology & Biostatistics 10.2 Drug Literature Evaluation & Evidence-Based Application 10.3 Medication Safety, Quality of Care, & Public Health

11 Chapter 11: Professional Practice: Systems & Management

11.1 Healthcare Regulations, Standards of Care, & Collaborative Practice 11.2 Pharmacoeconomics, Cost-Benefit Analysis, & Formulary Management

8.4 Social Determinants of Health in Treatment Planning

Key Takeaways Explain This Topic AI

Social determinants of health (SDOH) are the non-clinical conditions in which people live and work; they account for a large share of health outcomes and must be assessed during treatment planning.

Healthy People 2030 groups SDOH into five domains: economic stability, education access and quality, health care access and quality, neighborhood and built environment, and social and community context.

Validated screening tools such as PRAPARE and the CMS Accountable Health Communities tool structure SDOH data collection so pharmacotherapy plans address cost, transportation, food, and housing barriers.

A pharmacotherapy plan that ignores affordability, health literacy, or access predictably fails; SDOH-informed selection (generics, 90-day fills, once-daily regimens, patient-assistance programs) improves adherence and outcomes.

Last updated: July 2026

SDOH as a Treatment-Planning Competency

The September 2024 Pharmacotherapy Content Outline places Social Determinants of Health (2A6) inside Domain 2A, Treatment Planning. Its position is deliberate: SDOH are not a public-health afterthought but a factor that must be integrated when the plan is built , alongside diagnosis, pharmacokinetics, and goals of care. A technically perfect regimen the patient cannot afford, obtain, or understand is not a good plan.

Social determinants of health are the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect health, functioning, and quality-of-life outcomes. Population-health research consistently attributes the majority of health outcomes to these non-clinical factors rather than to medical care itself, which is why the exam expects pharmacotherapy specialists to screen for and act on them.

The Five Healthy People 2030 Domains

Healthy People 2030 organizes SDOH into five domains. Candidates should be able to map a patient barrier to the correct domain and to a pharmacotherapy consequence.

Domain Examples Pharmacotherapy consequence

Economic Stability Income, employment, medication cost, food insecurity Cost-related non-adherence; skipped or split doses

Education Access & Quality Literacy, numeracy, health literacy Misunderstood dosing; inability to interpret labels

Health Care Access & Quality Insurance, provider availability, telehealth, transportation Missed refills and appointments; therapeutic gaps

Neighborhood & Built Environment Housing stability, pharmacy deserts, safety, healthy-food access No refrigeration for insulin; unfilled prescriptions

Social & Community Context Social support, isolation, discrimination, incarceration history No caregiver for complex regimens; distrust of the system

Food, Housing, and Transportation Insecurity

Three high-yield, actionable barriers recur on the exam:

Food insecurity undermines diabetes and heart-failure regimens (hypoglycemia risk with sulfonylureas/insulin when meals are skipped; sodium-dense cheap food worsens fluid overload).

Housing instability eliminates safe medication storage (insulin, biologics requiring refrigeration) and disrupts mail-order pharmacy.

Transportation barriers drive missed appointments and lapsed refills; 90-day supplies, mail-order, and synchronized fills mitigate them.

Screening for SDOH

SDOH assessment should be systematic , not ad hoc, because clinicians cannot reliably infer barriers from appearance or education level. Validated instruments the exam recognizes include:

PRAPARE (Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences) — a widely used, standardized SDOH screening tool.

CMS Accountable Health Communities (AHC) Health-Related Social Needs Screening Tool — screens housing, food, transportation, utilities, and interpersonal safety.

Health Leads and the AAFP Social Needs Screening Tool — brief clinic-based screens.

Structured screening lets the pharmacotherapy plan connect patients to resources (patient-assistance programs, 340B pricing, food banks, medication-therapy management, community health workers) rather than simply documenting a problem.

Translating SDOH into the Pharmacotherapy Plan

An SDOH-informed plan changes concrete drug decisions:

Affordability: choose generics and formulary-preferred agents; use combination pills to reduce copays; enroll patients in manufacturer patient-assistance programs or use $4 generic lists ; prescribe 90-day fills to cut per-fill costs and pharmacy trips.

Access: favor once-daily or long-acting regimens when adherence is limited by work or caregiving; use mail-order or synchronized refills for pharmacy deserts and transportation barriers; leverage telehealth follow-up.

Health literacy: apply teach-back , plain language at a 5th-6th grade level, pictograms, and pill organizers.

Storage and stability: avoid refrigeration-dependent products for patients with unstable housing when equivalent room-temperature options exist.

A Worked Treatment-Planning Example

Consider a 58-year-old uninsured man with newly diagnosed type 2 diabetes (A1c 10.2%), stage 3 chronic kidney disease, and atherosclerotic cardiovascular disease who works two hourly jobs, has no reliable transportation, and reads at a 4th-grade level. A guideline-first reflex might reach for an SGLT2 inhibitor plus a GLP-1 receptor agonist because both carry cardiorenal benefit. But an SDOH-informed plan weighs each barrier:

Economic stability: brand-only injectable GLP-1 agonists may be unaffordable; start with metformin and a low-cost sulfonylurea or an SGLT2 inhibitor through a patient-assistance program, and pursue 340B pricing or manufacturer coupons before prescribing a high-cost agent.

Health care access & transportation: consolidate to once-daily dosing and 90-day mail-order fills, and schedule telehealth follow-up to avoid missed clinic visits.

Education/health literacy: counsel with teach-back and pictograms; provide a written plan at a 5th-6th grade reading level and a pill organizer.

Social & community context: refer to a community health worker and diabetes self-management education, and screen for food insecurity that could make insulin dosing unsafe.

The resulting plan is still guideline-concordant but is now achievable , which is precisely the judgment the BCPS tests.

SDOH, Equity, and Documentation

SDOH data can be captured with ICD-10 Z-codes (Z55-Z65) , supporting population-health management and value-based-care metrics. Addressing SDOH is a recognized strategy to reduce health disparities and improve medication adherence, and it distinguishes a specialist-level plan from a rote guideline recitation. The BCPS expects the candidate to identify the barrier, map it to a domain, and select a pharmacotherapy adjustment or referral that makes the guideline-concordant plan actually achievable.